QC
DGX icon

Quadrature Capital’s Quest Diagnostics DGX Stock Holding History

Quadrature Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,233
Closed -$812K – 1116
2024
Q3 		$812K Sell
5,233
-20,796
-80% -$3.11M 0.02% 400
2024
Q2 		$3.56M Buy
26,029
+5,625
+28% +$770K 0.06% 230
2024
Q1 		$2.72M Sell
20,404
-13,802
-40% -$1.79M 0.05% 247
2023
Q4 		$4.71M Buy
+34,206
New +$4.5M 0.09% 147
2022
Q4 		– Sell
-34,483
Closed -$4.23M – 906
2022
Q3 		$4.23M Buy
34,483
+13,443
+64% +$1.77M 0.14% 157
2022
Q2 		$2.8M Buy
+21,040
New +$2.87M 0.12% 178
2022
Q1 		– Sell
-4,614
Closed -$799K – 768
2021
Q4 		$799K Buy
+4,614
New +$702K 0.04% 268
2021
Q2 		– Sell
-7,500
Closed -$963K – 1001
2021
Q1 		$963K Buy
+7,500
New +$924K 0.05% 325
2020
Q2 		– Sell
-7,313
Closed -$587K – 654
2020
Q1 		$587K Buy
+7,313
New +$757K 0.14% 207
2018
Q1 		– Sell
-2,537
Closed -$250K – 632
2017
Q4 		$250K Sell
2,537
-31,734
-93% -$3.01M 0.02% 437
2017
Q3 		$3.21M Buy
34,271
+11,439
+50% +$1.21M 0.4% 58
2017
Q2 		$2.54M Buy
+22,832
New +$2.41M 0.2% 119
2017
Q1 		– Sell
-13,337
Closed -$1.23M – 697
2016
Q4 		$1.23M Buy
+13,337
New +$1.15M 0.08% 258

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quadrature Capital's DGX Position: Q4 2024 in Review

Quadrature Capital sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 5,233 shares — an estimated $812K sold.

Quadrature Capital first reported a position in DGX in Q4 2016 and held it in 13 quarters. The position peaked at $4.71M in Q4 2023. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Quadrature Capital reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Quadrature Capital sold 5,233 Quest Diagnostics shares in Q4 2024, an estimated $812K.
  • Quadrature Capital first reported a position in Quest Diagnostics in Q4 2016 and held it in 13 quarters.
  • Quadrature Capital's Quest Diagnostics position peaked at $4.71M in Q4 2023.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Quadrature Capital's 13F filing for Q4 2024, filed 13 Feb 2025.